Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.

22.90 0.60 −2.55%
Market cap
$3.8B
P/E
38.8×
Fwd P/E
24.4×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
44.66 60.40 77.54 226.33

+8 more quarters

P/S ratio
1.49 1.48 1.34 1.29
P/FCF ratio
17.13 18.87 15.80 12.86
P/Operating CF
35.79 (1,260.04) 33.77 42.99
P/B ratio
1.39 1.35 1.17 1.10
Price to Tangible BV
38.96 47.96 30.17 42.45
EV/Sales
1.64 1.65 1.47 1.45
EV/EBITDA
10.94 11.68 10.78 11.14
EV/Operating CF
15.51 17.02 14.51 12.70
EV/FCF
18.85 21.02 17.32 14.49
Quick Ratio
1.94 1.93 1.93 1.87
Current Ratio
2.43 2.44 2.38 2.37
Net Debt/EBITDA
2.62 3.50 2.11 3.23
Debt/Assets
25.66% 25.80% 25.50% 25.62%
Debt/Equity
0.47 0.47 0.47 0.47
Asset Turnover
0.51 0.51 0.49 0.47
Operating CF/Net income
2.22 (0.09) 3.28 (2.60)
Capex/Depreciation
(0.37) (0.32) (0.42) (0.28)
Interest Coverage
9.23 8.45 7.12 6.39
Research and Development Expense of Revenue
4.16% 4.25% 4.28% 4.22%
Selling, General and Administrative Expense of Revenue
40.56% 42.18% 40.66% 42.45%
Intangible Assets out of Total Assets
0.53 0.54 0.53 0.53
Share Based Compensation of Revenue
1.30% 1.45% 1.39% 1.55%
Graham Net Nets
(0.13) (0.14) (0.15) (0.18)
Graham Number
15.88 13.33 10.79 6.14
Earnings Yield
2.24% 1.66% 1.29% 0.44%
Free Cash Flow Yield
5.84% 5.30% 6.33% 7.78%
Revenue per Share
4.51 4.30 4.47 4.03
Operating CF per Share
0.74 (0.02) 0.64 0.47
Capex per Share
(0.09) (0.08) (0.10) (0.06)
Free Cash Flow per Share
0.65 (0.10) 0.55 0.41
Cash per Share
6.95 6.61 7.21 6.83
Shareholders Equity per Share
19.00 18.79 18.49 18.59
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
19.00 18.79 18.49 18.59
Free Cash Flow
105.10 (15.70) 91.70 67.90
Working Capital
1,150.70 1,132.50 1,174.00 1,126.60
Capital Expenditures
(14.10) (12.40) (16.30) (10.80)
Net Current Asset Value
(562.80) (579.40) (546.10) (606.00)
EV/EBIT
17.15 19.33 18.51 20.18
Capex to Sales
0.02 0.02 0.02 0.02
Price to Operating Income
15.59 17.35 16.88 17.91
Other line items
Average Receivables
429.85 414.85 396.30 399.00
Average Payables
181.00 166.75 183.10 164.05
Average Inventory
286.40 280.80 264.55 278.20
Average Assets
5,630.75 5,522.20 5,514.75 5,576.60
Average Common Equity
3,107.65 3,057.80 3,020.55 3,080.35

Fold the line items

Columns are period end dates